14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $116.30 $116.30 Thursday, 4th Jan 2024 HZNP stock ended at $116.30. During the day the stock fluctuated 0% from a day low at $116.30 to a day high of $116.30.
90 days $116.30 $116.30
52 weeks $90.61 $116.38

Historical Horizon Therapeutics Public Limited Company prices

Date Open High Low Close Volume
Mar 20, 2023 $109.13 $109.20 $108.64 $108.71 1 559 753
Mar 17, 2023 $109.75 $109.79 $109.00 $109.06 2 318 774
Mar 16, 2023 $109.58 $109.61 $109.29 $109.58 1 321 778
Mar 15, 2023 $109.82 $109.82 $109.25 $109.47 2 106 752
Mar 14, 2023 $109.80 $109.91 $109.60 $109.70 951 142
Mar 13, 2023 $109.77 $110.17 $109.33 $109.45 1 826 904
Mar 10, 2023 $109.55 $110.06 $109.43 $110.04 892 591
Mar 09, 2023 $109.99 $110.00 $109.49 $109.65 1 139 584
Mar 08, 2023 $109.90 $110.05 $109.62 $109.80 735 370
Mar 07, 2023 $109.87 $110.06 $109.70 $109.96 2 851 444
Mar 06, 2023 $110.02 $110.18 $109.73 $109.80 1 907 943
Mar 03, 2023 $110.25 $110.54 $109.88 $110.05 1 217 808
Mar 02, 2023 $110.02 $110.49 $109.96 $110.25 1 250 637
Mar 01, 2023 $109.49 $110.49 $109.25 $110.34 2 272 524
Feb 28, 2023 $109.84 $110.36 $109.47 $109.49 3 612 109
Feb 27, 2023 $110.59 $110.64 $109.78 $109.84 2 267 110
Feb 24, 2023 $110.55 $110.85 $110.10 $110.50 1 467 606
Feb 23, 2023 $110.77 $111.07 $110.48 $110.70 1 983 776
Feb 22, 2023 $110.11 $110.94 $110.11 $110.76 2 288 126
Feb 21, 2023 $109.78 $110.18 $109.78 $109.88 1 087 391
Feb 17, 2023 $109.62 $110.34 $109.47 $109.93 1 944 674
Feb 16, 2023 $109.51 $109.85 $109.48 $109.62 1 295 615
Feb 15, 2023 $109.58 $109.96 $109.56 $109.68 1 538 770
Feb 14, 2023 $109.60 $109.82 $109.41 $109.55 1 157 170
Feb 13, 2023 $109.83 $109.85 $109.50 $109.51 1 029 864
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT